Inovio Pharmaceuticals Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | 100.0% | 100.0% | – | – | – | – | – | – | |
| 215.1% | 280.9% | 236.5% | 117.0% | 964.6% | 280.4% | 1,606.8% | 91.9% | 1,092.1% | 1,053.5% | 861.9% | 16,573.9% | 2,207.6% | 7,193.1% | 1,439.9% | 8,374.9% | 11,201.3% | 471.3% | 10,520.7% | 25,953.9% | 16,143.0% | 164.4% | 28,119.5% | 179.8% | 14.9% | 1,081.7% | 1,002.3% | 506.0% | 265.9% | 170.7% | – | 822.4% | – | 663.1% | – | – | – | – | – | – | – | |
| -115.1% | -180.9% | -136.5% | -17.0% | -864.6% | -180.4% | -1,506.8% | 8.1% | -992.1% | -953.5% | -761.9% | -16,473.9% | -2,107.6% | -7,093.1% | 100.0% | -8,274.9% | 100.0% | -371.3% | 100.0% | 100.0% | 100.0% | -64.4% | 100.0% | 100.0% | 100.0% | -981.7% | -902.3% | 100.0% | 100.0% | -70.7% | – | -722.4% | – | -563.1% | 100.0% | – | – | – | – | – | – | |
| 215.1% | 280.9% | 236.5% | 117.0% | 964.6% | 280.4% | 1,606.8% | 91.9% | 1,092.1% | 1,053.5% | 861.9% | 16,573.9% | 2,207.6% | 7,873.0% | 1,439.9% | 8,374.9% | 11,201.3% | 471.3% | 10,520.7% | 25,953.9% | 16,143.0% | 10,999.5% | 28,119.5% | 7,198.5% | 361.4% | 33,786.2% | 26,253.5% | 10,507.5% | 3,991.0% | 16,807.5% | – | 22,916.4% | – | 11,013.8% | 24,625,288.1% | – | – | – | – | – | – | |
| 45.9% | 81.8% | 74.9% | 30.2% | 239.0% | 91.4% | 634.0% | 29.4% | 339.4% | 225.2% | 246.5% | 4,311.9% | 655.4% | 3,111.6% | 561.2% | 4,143.7% | 4,280.9% | 154.4% | 3,740.4% | 4,642.7% | 4,510.2% | 1,674.2% | 8,013.8% | 6,177.6% | 129.2% | 11,190.7% | 12,084.8% | 5,984.4% | 2,555.1% | 9,978.8% | – | 10,129,499.2% | – | 6,497.0% | 13,811,686.0% | – | – | – | – | – | – | |
| 261.0% | 362.7% | 311.4% | 147.2% | 1,203.6% | 371.8% | 2,240.8% | 121.3% | 1,431.6% | 1,278.7% | 1,108.3% | 20,885.8% | 2,863.0% | 10,984.6% | 2,001.1% | 12,518.6% | 15,482.2% | 625.7% | 14,261.1% | 30,596.6% | 20,653.2% | 12,509.4% | 36,133.3% | 13,376.1% | 490.6% | 43,895.1% | 37,335.9% | 16,492.0% | 9,252.6% | 26,615.6% | – | 32,223.5% | – | 16,847.6% | 38,436,974.1% | – | – | – | – | – | – | |
| -161.0% | -262.7% | -211.4% | -47.2% | -1,103.6% | -260.5% | -2,140.8% | -21.3% | -1,331.6% | -1,178.7% | -1,008.3% | -20,785.8% | -2,763.0% | -10,884.6% | -1,901.1% | -12,418.6% | -15,382.2% | -525.7% | -14,161.1% | -30,496.6% | -20,553.2% | -12,573.8% | -36,033.3% | -13,276.1% | -390.6% | -44,876.8% | -38,238.2% | -16,392.0% | -9,152.6% | -26,686.3% | – | -32,945.9% | – | -17,410.8% | -38,337.0% | – | – | – | – | – | – | |
| 4.5% | 45.5% | 11.1% | 0.8% | 187.1% | 15.7% | 159.3% | 5.9% | 81.3% | 138.4% | 26.4% | 1,617.7% | 280.2% | 954.9% | 211.2% | 1,065.4% | 840.1% | 19.1% | 138.2% | 171.1% | 163.3% | 57.2% | 157.5% | 40.0% | 3.4% | 251.5% | 272.7% | 138.7% | 80.7% | 275.0% | – | 0.0% | – | 0.0% | 0.0% | – | – | – | – | – | – | |
| -165.5% | -308.1% | -222.5% | -46.4% | -1,290.8% | -244.7% | -1,973.1% | -27.2% | -1,250.2% | -1,317.1% | -1,037.2% | -21,880.4% | -2,715.1% | -13,680.4% | -2,496.5% | -48,007.8% | 8,117.3% | -401.7% | -14,658.9% | -30,107.3% | -20,627.2% | -12,745.3% | -39,720.8% | -13,832.0% | -412.8% | -43,687.2% | -35,364.8% | -15,725.3% | -8,734.8% | -24,357.9% | – | -31,993.3% | – | -16,566.4% | -30,140.5% | – | – | – | – | – | – | |
| 4.5% | 37.9% | 10.0% | 0.8% | 171.1% | -45.1% | 141.9% | 4.8% | -92.7% | 138.4% | -2.2% | -78.7% | -149.5% | -31.4% | 1,331.9% | 35,117.2% | -12,606.1% | -86.4% | 345.5% | -50.0% | 156.1% | 245.0% | 3,519.2% | 505.8% | 20.0% | -2,241.9% | -2,600,743.8% | -423.8% | -265.9% | 0.0% | – | 0.0% | – | -612.4% | – | – | – | – | – | – | – | |
| -165.5% | -308.1% | -222.5% | -46.4% | -1,290.8% | -244.7% | -2,114.9% | -27.2% | -1,250.2% | -1,317.1% | -1,032.5% | -21,660.3% | -2,663.7% | -13,475.4% | -2,451.7% | -48,169.7% | 8,117.3% | -436.1% | -14,658.9% | -30,107.3% | -20,627.2% | -12,745.3% | -39,720.8% | -13,832.0% | -412.8% | -43,687.2% | -35,364.8% | -15,725.3% | -8,734.8% | -24,357.9% | – | -31,993.3% | – | -16,566.4% | -30,140.5% | – | – | – | – | – | – | |
| -154.0% | -253.0% | -202.4% | -42.8% | -1,059.6% | -266.4% | -2,055.7% | -22.0% | -1,190.6% | -1,129.0% | -971.7% | -19,379.1% | -2,333.1% | -12,020.6% | -2,193.5% | -46,500.2% | 10,063.3% | -348.6% | -14,113.8% | -29,525.5% | -20,067.8% | -12,523.7% | -37,784.6% | -13,612.2% | -394.5% | -42,354.1% | -34,089.7% | -15,080.5% | -8,388.2% | -23,912.2% | – | -31,170.9% | – | -15,903.3% | -38,336,974.1% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.